Steven Tau

Steven is leveraging metabolic and REDOX vulnerabilities in residual breast cancers cells that remain following anti-estrogen therapy to develop novel therapeutic approaches.
Steven is leveraging metabolic and REDOX vulnerabilities in residual breast cancers cells that remain following anti-estrogen therapy to develop novel therapeutic approaches.
Miller Laboratory
Dartmouth-Hitchcock Medical Center
One Medical Center Drive, HB-7936
Lebanon, NH 03756
(603) 646-5507
Todd.W.Miller@Dartmouth.edu